Frontiers in Genetics · 2022 · 12 citations · 11 references
Life SciencesGeneticsImmunologyHypersensitivityImmunogeneticsRheumatologyAutoimmune DiseasesAutoimmune Skin DiseasesGenetic Susceptibility To AutoimmunityGoutHla TypingCutaneous Adverse EventsHla Allele Frequency DistributionHla Allele PolymorphismHla AllelesHla Genotype AssociationsHla Risk AllelesHla-associated Adverse Drug ReactionsSevere Cutaneous Adverse Reactions
Background: Allopurinol is the most commonly used drug for the treatment of gout arthritis. However, the use of allopurinol is associated with severe cutaneous adverse reactions (SCARs) and life-threatening immune-mediated reactions that include Stevens–Johnson syndrome (SJS). SJS induced by allopurinol is strongly linked with the presence of HLA-B*58:01 in the Asian population. Such a study has not been conducted in Indonesia. We present two cases with clinical diagnosis of SJS. These patients had Javanese ethnicity, for which evidence on the genetic predisposition of allopurinol-induced SJS/TEN had not been established. Testing for the presence of the HLA-B∗58:01 allele was positive in both cases. Our case report confirms findings from studies in Asian countries that link HLA-B*58:01 and allopurinol-induced SJS/TEN. A larger study is needed to elicit evidence that the HLA-B*58:01 allele can potentially be used as a genetic marker for allopurinol-induced SCARs among different ethnicities in Indonesia.
11
Yoshiro Saito, L. Dudley Stamp, KE Caudle et al. · Clinical Pharmacology & Therapeutics · 2015 · 157 citations · Full text
Diagnosis, treatment, and prevention of gout.
B L Hainer, Eric M. Matheson, Ruth Wilkes · PubMed · 2014 · 127 citations